Cor Vasa 2019, 61(5):489-493 | DOI: 10.1016/j.crvasa.2018.09.006

(Interventricular septal defect as a complication of a concomitant aortic valve replacement and aortocoronary bypass surgery)

Tomáš Toporcera, Karol Trejbalb, Martin Ledeckýa, Martin Sivčoa, Adrián Kolesára, František Sabola
a Klinika srdcovej chirurgie, Lekárska fakulta Univerzity Pavla Jozefa Šafárika a Východoslovenský ústav srdcových a cievnych chorôb a.s., Košice, Slovensko
b Klinika anesteziológie a intenzívnej medicíny, Východoslovenský ústav srdcových a cievnych chorôb a.s., Košice, Slovensko

Ventricular septal defect (VSD) is a rare complication of surgical aortic valve replacement (AVR) and transcatheter aortic valve replacement (TAVI), with an incidence of 1%. An 81-year-old man underwent AVR with double aortocoronary bypass. Several hours after surgery haemodynamic instability accrued, and echocardiography showed a VSD. The patient underwent another surgery with the use of cardiopulmonary bypass. The VSD was closed through aortothomy, and annuloplasty of the tricuspid valve was performed. The postoperative period was complicated by atrioventricular block, with pacemaker implantation required. There are more possibilities for VSD treatment in the literature. On one hand, percutaneous device closure allows for a procedure without mechanical protheses explantation. On the other hand, surgical access through the aortothomy is useful in the case of a progressive and dynamic increase of the VSD and the proximity of the prothesis and the VSD. A combined approach for implantation of an occluder under visual inspection is presented as an additional applicable treatment strategy.

Keywords: Aortic valve replacement, Aortic valve stenosis, Interventricular septal defect

Published: October 20, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Toporcer T, Trejbal K, Ledecký M, Sivčo M, Kolesár A, Sabol F. (Interventricular septal defect as a complication of a concomitant aortic valve replacement and aortocoronary bypass surgery). Cor Vasa. 2019;61(5):489-493. doi: 10.1016/j.crvasa.2018.09.006.
Download citation

References

  1. Mathieu P, Arsenault BJ, Boulanger MC, et al. Pathobiology of Lp(a) in calcific aortic valve disease. Expert Rev Cardiovasc Ther 2017;15:797-807. Go to original source... Go to PubMed...
  2. Garrido JM, Ferreiro A, Samaranch N, et al. Interventricular septal rupture after transcatheter aortic valve implantation: surgical and perioperative management. J Card Surg 2014;29:478-481. Go to original source... Go to PubMed...
  3. Sardar MR, Khan ZA, Abraham A, et al. Management strategies and possible risk factors for ventricular septal defects after transcatheter aortic valve replacement: Case series from a single center and review of literature. Cardiovasc Revasc Med 2017;18:462-470. Go to original source... Go to PubMed...
  4. Lorenz J, Reddy CV, Khan R, et al. Aortico-right ventricular shunt following aortic valve replacement, Chest 1983;83:922-925. Go to original source... Go to PubMed...
  5. Taleyratne JD, Henderson RA. Transcatheter Closure of Iatrogenic VSDs after Aortic Valve Replacement Surgery: 2 Case Reports and a Literature Review. Tex Heart Inst J 2016;43:329-333. Go to original source... Go to PubMed...
  6. Mark SD, Prasanna V, Ferrari VA, et al. Percutaneous Ventricular Septal Defect Closure After Sapien 3 Transcatheter Aortic Valve Replacement. JACC Cardiovasc Interv 2015;8:e109-e110. Go to original source... Go to PubMed...
  7. Gerckens U, Latsios G, Pizzulli L. Percutaneous treatment of a post-TAVI ventricular septal defect: a successful combined procedure for an unusual complication, Catheter Cardiovasc Interv 2013;81:E274-E277. Go to original source... Go to PubMed...
  8. Hamm K, Reents W, Kerber S, et al. Closure of a high ventricular septal defect after transcatheter aortic valve implantation with an atrial septal occluder-hybrid treatment for a rare complication. Eur J Cardiothorac Surg 2017;51:600-602. Go to original source...
  9. Siebers C, Schramm R, Friedmann A, et al. Severe cardiogenic shock due to acute onset of an aorto-to-right atrial shunt in a patient with aortic valve endocarditis. Int J Surg Case Rep 2014;5:108-110. Go to original source... Go to PubMed...
  10. Toporcer T, Kolesár A, Ledecký M, et al. Late infective endocarditis of an Amplatzer atrial septal device twelve years after implantation. Cor Vasa 2018;60:e174-e178. Go to original source...
  11. Ando T, Holmes AA, Taub CC, et al. Iatrogenic Ventricular Septal Defect Following Transcatheter Aortic Valve Replacement: A Systematic Review. Heart Lung Circ 2016;25:968-974. Go to original source... Go to PubMed...
  12. Ryu IH, Kim WH, Ryu AJ, et al. Percutaneous closure of an iatrogenic ventricular septal defect following concomitant septal myectomy at the time of aortic valve replacement. Korean Circ J 2014;44:45-48. Go to original source... Go to PubMed...
  13. Greason KL, Lahr BD, Stulak JM, et al. Long-Term Mortality Effect of Early Pacemaker Implantation After Surgical Aortic Valve Replacement. Ann Thorac Surg 2017;104:1259-1264. Go to original source... Go to PubMed...
  14. Rene AG, Sastry A, Horowitz JM, et al., Recovery of atrioventricular conduction after pacemaker placement following cardiac valvular surgery. J Cardiovasc Electrophysiol 2013;24:1383-1387. Go to original source... Go to PubMed...
  15. Toporcer T, Luczy J, Kolesár A, et al. The effect of surgical access for mitral valve surgery on incidence of atrial fibrillation and atrioventricular block. Cor Vasa 2017;59:e381-e388. Go to original source...

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.





Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.